NCT05005520View on ClinicalTrials.gov

Study of DTRI-031 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

October 20, 2021

Primary Completion Date

April 19, 2022

Study Completion Date

April 19, 2022

Conditions
Healthy VolunteersPharmacokineticsPharmacodynamics
Interventions
DRUG

DTRI-031

Investigational drug

DRUG

Placebo

Matching placebo to DTRI-031

Trial Locations (1)

3004

Nucleus Network, Melbourne

Sponsors
All Listed Sponsors
lead

Basking Biosciences, Inc.

INDUSTRY